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China is one of the fastest developing countries in the world. Rapid economic progress has resulted in changes to both diet and
physical activity. New found prosperity, increased urban migration, and the adoption of sedentary lifestyles by an aging Chinese
population have resulted in a dramatic shift in disease burden—from infectious to chronic. Modern Chinese ﬁnd themselves in-
creasingly aﬄicted with the same noncommunicable chronic diseases typical of industrialized nations. Today, cardiovascular dis-
ease is the number one cause of both morbidity and mortality, aﬀecting both rural and urban Chinese. The rising incidence of
cardiovascular disease has been fueled by an epidemic of cardiometabolic risk factors. While hypertension and smoking have
received considerable spotlight, little attention has been given to obesity, diabetes, and metabolic syndrome. Their increasing prev-
alence is the focus of this paper.
1.Introduction
China is one of the fastest developing countries in the world.
Since embracing market reforms in 1979, the country has
experienced unequaled economic growth and has sustained
an average of GDP growth of over eight percent for near-
ly three decades. Meanwhile, increased global trade and
advances in agriculture have led to food surpluses in a coun-
try previously plagued by severe cyclical famine. This, cou-
pled with improvements in sanitation and immunization,
has dramatically raised average life expectancy from 46.6
years in 1960 to 73.1 years in 2009 [1]. Increased longevity,
urbanization, and changes in traditional diets have resulted
in an epidemic of cardiovascular disease (CVD). Today, CVD
is the leading cause of both morbidity and mortality in
China, responsible for one-third of all annual deaths [1, 2].
The increased burden of CVD can be attributed, in part, to
the rapid rise in risk factors hypertension, smoking, obesity,
diabetes mellitus, and metabolic syndrome. Considerable
attention has already been given to both smoking and hy-
pertension. However, while the prevalence of smoking
remains high, its incidence peaked in the mid 1990s, and
currently it is expected to decline over the next three
decades [3]. In the meantime, rates of obesity, diabetes, and
metabolic syndrome are projected to rise considerably. These
cardiometabolic risk factors will play an increasingly impor-
tant role in the rising CVD epidemic in China and deserve
special attention.
2.Obesity
O b e s i t yi sa ne x c e s so fb o d yf a t ,d e ﬁ n e di nw e s t e r np o p u l a -
tions by Body Mass Index >30kg/m2 [14]. It is a known risk
factor for the development of atherosclerotic cardiovascular
disease,type2diabetes,dyslipidemia,andhypertension[15].
There is a growing body of evidence that demonstrate for
any given BMI Asians have a greater percentage of body fat
and a higher cardiovascular risk [10, 16–18]. In addition,
Chinese people are more likely to develop central obesity,
which has been associated with a higher risk of developing
cardiovascular disease [19]. Based on these studies, the
Working Group on Obesity in China recommended a BMI2 Cardiology Research and Practice
Table 1: Obesity trends 1992–2002 [4].
Classiﬁcation
BMI Kg/m2
Prevalence (%) Percent change
1992–2002
Estimated number of
overweight & obese chinese∗
1992 2002
Overweight
24.0–27.9 16.4 22.8 39.0% 305,748,000
Obese > 28.0 3.6 7.1 97.2% 95,211,000
Adapted from [5].
∗Based on a population statistics reported by the Chinese Bureau of Statistics, 2011.
Table 2: Awareness, treatment, and control of diabetes in Chineset.
Population Awareness Treatment Control
China 23.7% 4.81% 0.40%
tPercentage of total diabetics.
Adapted from [6].
cutoﬀ of 24kg/m2 and 28kg/m2, for overweight and obesity,
respectively [20]. The Chinese Ministry of Health has incor-
porated these cutoﬀs in guidelines to prevent and control
overweight and obesity in Chinese adults [20].
Rapid economic development and industrialization have
led to changes in traditional diets and increasingly sedentary
lifestyles [21, 22]. China, once considered one of the leanest
populations in the world, has experienced rapidly escalating
rates of overweight and obesity. A recent meta-analysis of
nationally representative data by Wang [5] estimated that
the prevalence of overweight and obesity rose 49.5 percent
between 1992 and 2002, from 20.0 to 29.9 percent (using the
WGOC cutoﬀ for overweight and obesity) (Table 1). The rise
has been greatest in urban high-income populations, such as
Beijing.Similarrateshavebeenfoundinotherstudies[4,23],
translatingintoanestimated401millionoverweightorobese
Chinese.
In 2003, the total medical cost attributable to overweight
and obesity was estimated at 2.6 billion USD, or 3.7 percent
of total national medical costs [24]. The prevalence of over-
weight and obesity and it’s economic burden on the Chinese
healthcare system will only increase as greater numbers of
rural Chinese move into the ranks of the urban middle class.
3.Diabetes
Changes in diet and lifestyle have also led to a tremendous
increase in the number of Chinese with obesity-related type
2 diabetes mellitus (T2DM). Diabetes is a major risk factor
for cardiovascular disease and its prevalence has increased
dramatically in the past two decades. In 1994, the prevalence
of DM and IGT among individuals between 25 and 64 years
was estimated to be 2.6 percent and 3.2 percent, respectively
[25]. By 2001, the prevalence of diabetes and IGT had
increased to 5.49 percent and 7.33 percent, respectively [26].
In 2008, the prevalence of diabetes and IGT in Chinese
>20 years old had risen to 9.7 percent and 15.5 percent,
respectively [27], (Figure 1).
Alarmingly, the prevalence of diabetes in China has
nearly quadrupled over the last 15 years. Although the preva-
lence of DM and IGT remain lower than that of other
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Figure 1: Prevalence of diabetes mellitus and impaired glucose
tolerance in China 1994–2008. Adapted from [25–27].
industrialized nations, such as the USA, China’s enormous
population,estimatedtobeover1.3billion,makesithometo
the largest diabetic population in the world. Today, there are
92.4 million Chinese suﬀering from diabetes, with an addi-
tional 148.2 million living with impaired glucose tolerance
[27].
Despite the increasing prevalence of diabetes in China,
rates of awareness, treatment, and control remain low. In
2000, a nationally representative study of 15,236 Chinese
adultsfoundthatnearly75percentofdiabeticswereunaware
of their diagnosis [6]. Of those that were aware, only 20
percent were taking prescribed medications or pursuing
nonpharmacological interventions (exercise or dietary mod-
iﬁcation), of these, only 8.3 percent managed to achieve
glycemic control [6]( Table 2). Similar rates of awareness
were reported by Yang et al., 2010 [27]. Based on these
estimates, there are currently 84.7 million Chinese with
uncontrolled diabetes mellitus. They are at increased risk for
developing long-term complications including cardiovascu-
lar disease, renal disease, peripheral neuropathy, retinopathy,
and blindness. In 2007, the direct medical costs of obesity-
related DM and its complication were estimated to be 26
billion USD, representing 16 percent of all Chinese medicalCardiology Research and Practice 3
Table 3: NCEP ATP III diagnostic criteria for metabolic syndrome [7–9].
Criteria Category
Elevated fasting glucose ≥110mg/dL or use of antidiabetic medications±
Elevated triglycerides ≥150mg/dL
Reduced HDLC <40mg/dL in men
<50mg/dL in women
Elevated blood pressure
≥130mmHg or ≥85mmHg DBP or use of
antihypertensive medication
Elevated waist circumference >102cm in men
>88cm in women
WHO modiﬁed Asian waist circumference criteria [10]
Elevated waist circumference >90cm in men
>80cm in women
±WHO classiﬁes fasting blood glucose >100mg/dL as elevated.
Adapted from [11–13].
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Figure 2: Prevalence of obesity, diabetes and, metabolic syndrome
trends over time 1992–2008.
expenditures.Ifcurrenttrendscontinue,thiscostisprojected
to increase to 47.2 billion USD by 2030 [28].
4. MetabolicSyndrome
The metabolic syndrome (MetS) is a combination of inter-
connected risk factors for obesity, insulin resistance and glu-
cose intolerance, dyslipidemia, and hypertension. The adult
treatment panel III of the National Cholesterol Education
Program (NCEP) deﬁned a group of ﬁve clinical criteria for
eﬀective classiﬁcation of MetS (Table 3).
An individual that meets three or more of these criteria
can be given the clinical diagnosis of MetS. The syndrome is
associated with the development of diabetes, cardiovascular,
and kidney disease, and an increased risk for mortality
[29, 30]. Based on the NCEP classiﬁcation, a rapidly growing
epidemic of metabolic syndrome is taking place in China.
In 1992, the prevalence of metabolic syndrome in China
was 13.3 percent, 12.7 percent in males and 14.2 percent in
females [31]. By 2000, the prevalence of metabolic syndrome
had increased to 15.1 percent, 13.6 percent in men and 16.6
percent in women [32]. This prevalence rate was determined
using the modiﬁed Asian criteria for waist circumference,
based on studies which have shown that Asians suﬀer from
the same risk of cardiovascular disease development at
smaller waist circumferences, 90cm for men and 80cm for
women [33, 34]. In 2000, 64 million Chinese had metabolic
syndrome, this number increases to 71 million using the
modiﬁed ATP III criteria for Asian populations [35].
Numerous studies have shown that the prevalence of
metabolic syndrome increases with age [35–37]. This ﬁnding
hasimportantimplicationsforChina,whoseenormouspop-
ulation is aging rapidly as an unintended consequence of
the “one child policy” adopted by the government in 1978.
The population of Chinese seniors grows by 3.3 percent
annually. By 2050, 30 percent of the population will be
over the age of 65 years [38]. The increasing prevalence
of MetS among elderly Chinese was demonstrated in a
Hong Kong-based population study by Thomas [39]. Of
participants aged 25–29 years, only 3.1 percent had MetS,
compared to 41.0 percent of those aged over 70 years. The
age- and gender-adjusted prevalence was 21.2 percent. This
approaches prevalence rates found in other industrialized
nations [40, 41]. The high prevalence of MetS among Hong
Kong Chinese forewarns a rapidly increasing problem in
Mainland, China. Hong Kong, with its vibrant economy
fostered by decades of British occupation has already gone
through the rapid socioeconomic changes the rest of the
country is currently experiencing. In addition, the rapid
inﬂux of rural Chinese into the country’s overcrowded meg-
acities will only accelerate the rapid rise in MetS and related
complications [42], (Figure 2).
5. Conclusion
China is a middle-income country in rapid economic and
epidemiologic transition. Decades of economic development
have led to dramatic changes in life expectancy, lifestyle, and
diet. An older more sedentary population ﬁnds itself increas-
ingly more burdened by diseases of its newfound wealth
obesity, diabetes, and metabolic syndrome, which already4 Cardiology Research and Practice
approach those found in industrialized nation in both
Europe and the USA. The increasing prevalence of car-
diometabolic risk factors has resulted in an unprecedented
rise in the incidence of cardiovascular disease. The incidence
of CVD is predicted to rise by at least 50% in the next 20
years, with an additional 23 percent increase resulting from
trends in cardiometabolic risk factors [43]. Perhaps even
more alarming, Chinese are less likely to be diagnosed and
less likely to gain control of their chronic disease [6, 44]
and have limited access to quality healthcare services [45,
46]. Furthermore, the Chinese healthcare system, with its
historical focus on treating infectious diseases, is ill equipped
to handle the rising epidemic of cardiovascular disease [47].
The Chinese have proven themselves capable of rapid large-
scale socioeconomic change. However, the ability of the
government to respond and control such an epidemic will
depend on whether or not it approaches the task with the
same vigor it has approached economic development. While
China can beneﬁt from the rich body of existing research
oncardiometabolicdisease,morestudiesonChinese-speciﬁc
risk factors are needed.
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